Literature DB >> 15753219

Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein.

Willibald Maier1, Lukas A Altwegg, Roberto Corti, Steffen Gay, Martin Hersberger, Friedrich E Maly, Gabor Sütsch, Marco Roffi, Michel Neidhart, Franz R Eberli, Felix C Tanner, Sharon Gobbi, Arnold von Eckardstein, Thomas F Lüscher.   

Abstract

BACKGROUND: Acute myocardial infarction (AMI) is associated with inflammation. However, it remains unclear whether it originates from the ruptured plaque or represents a systemic process. METHODS AND
RESULTS: In 42 patients with AMI, a balloon-based embolization protection device and aspiration catheter (PercuSurge) were used during acute coronary interventions. Samples from the site of the ruptured plaque were taken under distal balloon occlusion. Systemic samples were taken from the aorta. Sera, plaques, and thrombi were analyzed for inflammatory markers and lipoproteins. Systemic levels of C-reactive protein (CRP), interleukin-6 (IL-6), and serum amyloid A (SAA) in the aorta amounted to 3.0 mg/L, 5.0 ng/L, and 22.1 mg/L, respectively (interquartile ranges [IQRs], 1.1 to 7.4 mg/L, 5.0 to 6.5 ng/L, and 13.9 to 27.0 mg/L, respectively). In blood surrounding ruptured plaques, local levels of IL-6 (8.9 ng/L; IQR, 5.0 to 16.9 ng/L) and SAA (24.3 mg/L; IQR, 16.3 to 44.0 mg/L) were significantly higher, whereas CRP levels (2.5 mg/L; IQR, 0.9 to 7.7 mg/L) were decreased compared with the aorta (all P<0.0001). The coronary levels of IL-6 determined in vivo showed biological activity in vitro. Harvested thrombus contained CD68-positive monocytes expressing IL-6 and showed extracellularly and intracellularly positive staining for SAA, whereas CRP was found exclusively in the cytoplasm of phagocyting white blood cells.
CONCLUSIONS: Coronary levels of IL-6 and SAA at the site of plaque rupture were increased relative to the systemic circulation, indicating local production of biologically active inflammatory mediators. In contrast, CRP was locally decreased, at least in part by uptake by the phagocyting cells, suggesting a systemic origin of the protein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15753219     DOI: 10.1161/01.CIR.0000158479.58589.0A

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  55 in total

1.  Anticoagulant therapy for recurrent in-stent thrombosis following carotid artery stenting: A case report.

Authors:  Akinori Miyakoshi; Hiroki Toda; Makoto Hayase; Takeshi Kawauchi; Yuki Oichi; Etsuko Hattori
Journal:  Interv Neuroradiol       Date:  2017-06-21       Impact factor: 1.610

2.  C-reactive protein in vulnerable coronary plaques.

Authors:  Silja Norja; Lauri Nuutila; Pekka J Karhunen; Sirkka Goebeler
Journal:  J Clin Pathol       Date:  2006-06-21       Impact factor: 3.411

3.  "Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes.

Authors:  Peter A Kavsak; Dennis T Ko; Alice M Newman; Glenn E Palomaki; Viliam Lustig; Andrew R Macrae; Allan S Jaffe
Journal:  Clin Chim Acta       Date:  2007-10-03       Impact factor: 3.786

4.  CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion.

Authors:  Mohanraj Rajesh; Partha Mukhopadhyay; Sándor Bátkai; György Haskó; Lucas Liaudet; John W Huffman; Anna Csiszar; Zoltan Ungvari; Ken Mackie; Subroto Chatterjee; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-07-27       Impact factor: 4.733

Review 5.  Targeting angiogenesis to restore the microcirculation after reperfused MI.

Authors:  Anja M van der Laan; Jan J Piek; Niels van Royen
Journal:  Nat Rev Cardiol       Date:  2009-06-16       Impact factor: 32.419

Review 6.  Identification of myocardial injury in the emergency setting.

Authors:  Peter A Kavsak; Andrew Worster; John J You; Mark Oremus; Adell Elsharif; Stephen A Hill; P J Devereaux; Andrew R MacRae; Allan S Jaffe
Journal:  Clin Biochem       Date:  2009-12-21       Impact factor: 3.281

7.  Acute-phase protein serum amyloid A3 is a novel paracrine coupling factor that controls bone homeostasis.

Authors:  Roman Thaler; Ines Sturmlechner; Silvia Spitzer; Scott M Riester; Monika Rumpler; Jochen Zwerina; Klaus Klaushofer; Andre J van Wijnen; Franz Varga
Journal:  FASEB J       Date:  2014-12-09       Impact factor: 5.191

8.  Interleukin-6 release after carotid artery stenting and periprocedural new ischemic lesions.

Authors:  Yuko Abe; Manabu Sakaguchi; Shigetaka Furukado; Toshiyuki Fujinaka; Saburo Sakoda; Toshiki Yoshimine; Kazuo Kitagawa
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-02       Impact factor: 6.200

9.  Genome-wide association study identifies two novel regions at 11p15.5-p13 and 1p31 with major impact on acute-phase serum amyloid A.

Authors:  Carola Marzi; Eva Albrecht; Pirro G Hysi; Vasiliki Lagou; Melanie Waldenberger; Anke Tönjes; Inga Prokopenko; Katharina Heim; Hannah Blackburn; Janina S Ried; Marcus E Kleber; Massimo Mangino; Barbara Thorand; Annette Peters; Christopher J Hammond; Harald Grallert; Bernhard O Boehm; Peter Kovacs; Ludwig Geistlinger; Holger Prokisch; Bernhard R Winkelmann; Tim D Spector; H-Erich Wichmann; Michael Stumvoll; Nicole Soranzo; Winfried März; Wolfgang Koenig; Thomas Illig; Christian Gieger
Journal:  PLoS Genet       Date:  2010-11-18       Impact factor: 5.917

Review 10.  Immune modulation: role of the inflammatory cytokine cascade in the failing human heart.

Authors:  Mamoru Satoh; Yoshitaka Minami; Yuji Takahashi; Motoyuki Nakamura
Journal:  Curr Heart Fail Rep       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.